Help
RSS
API
Feed
Maltego
Contact
Domain > ir.palvellatx.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-03-29
23.63.72.185
(
ClassC
)
2025-12-01
23.46.228.178
(
ClassC
)
Port 443
HTTP/1.1 200 OKContent-Language: enContent-Security-Policy: default-src self bam-cell.nr-data.net bam.nr-data.net cm.everesttech.net thomsonreuterscorporategroupweb.sc.omtrdc.net *.demdex.net www.google-analytics.com www.googletagmanager.com www.adobetag.com *.facebook.net api.nasdaqomx.wallst.com www.google.com *.addthis.com *.addthisedge.com www.googleadservices.com thomsonreuterscorporategroupweb.d2.sc.omtrdc.net stats.g.doubleclick.net *.sharethis.com *.pixel.parsely.com www.recaptcha.net www.gstatic.com c212.net pixel.mathtag.com cdn.kscope.io *.globenewswire.com *.accesswire.com *.businesswire.com *.prnewswire.com *.c212.net *.youtube.com *.vimeo.com *.media-server.com ds-aksb-a.akamaihd.net sec.kscope.io media.corporate-ir.net *.unisonir.com http://cloudinary.com *.segment.com uninav.notified.com *.pendo.io *.pendo.notified.com data:; connect-src self *.uni.wdc.west.com *.sharethis.com *.unisonir.com *.demdex.net bam-cell.nr-data.net bam.nr-data.net api.segment.io thomsonreuterscorporategroupweb.sc.omtrdc.net *.akamaihd.net uninav.notified.com *.pendo.io intrado.kscope.io *.imirwin.com data:; font-src self fonts.googleapis.com cloud.typography.com fonts.gstatic.com uninav.notified.com stackpath.bootstrapcdn.com intrado.kscope.io *.fontawesome.com data:; frame-src self s7.addthis.com tools.eurolandir.com www.google.com *.sharethis.com api.nasdaqomx.wallst.com *.demdex.net www.recaptcha.net cloudinary.com https://player.cloudinary.com http://login.notified.com *.globenewswire.com; object-src self; script-src self unsafe-inline unsafe-eval *.recaptcha.net js-agent.newrelic.com *.jquery.com *.gstatic.com bam-cell.nr-data.net bam.nr-data.net *.akamaihd.net uninav.notified.com https://assets.adobedtm.com https://cdn.jsdelivr.net https://cdnjs.cloudflare.com https://code.jquery.com https://media-library.cloudinary.com https://uninav.notified.com https://unpkg.com https://upload-widget.cloudinary.com https://www.google.com https://www.recaptcha.net www.google.com; script-src-elem self unsafe-inline *.uni.wdc.west.com s7.addthis.com www.google.com www.googletagmanager.com www.google-analytics.com siteimproveanalytics.com cdn.parsely.com www.adobetag.com www.recaptcha.net www.gstatic.com *.sharethis.com ds-aksb-a.akamaihd.net sec.kscope.io *.unisonir.com js-agent.newrelic.com bam-cell.nr-data.net bam.nr-data.net code.jquery.com cdn.segment.com *.pendo.io *.notified.com intrado.kscope.io *.imirwin.com https://assets.adobedtm.com https://cdn.jsdelivr.net https://cdnjs.cloudflare.com https://code.jquery.com https://media-library.cloudinary.com https://uninav.notified.com https://unpkg.com https://upload-widget.cloudinary.com https://www.google.com https://www.recaptcha.net; style-src self unsafe-inline uninav.notified.com fonts.googleapis.com https://uninav.notified.com maxcdn.bootstrapcdn.com stackpath.bootstrapcdn.com *.gstatic.com https://fonts.googleapis.com https://unpkg.com https://use.fontawesome.com; style-src-elem self unsafe-inline fonts.googleapis.com *.uni.wdc.west.com *.sharethis.com www.google.com ajax.googleapis.com sec.kscope.io *.unisonir.com www.gstatic.com stackpath.bootstrapcdn.com maxcdn.bootstrapcdn.com *.notified.com *.pendo.io intrado.kscope.io https://fonts.googleapis.com https://uninav.notified.com https://unpkg.com https://use.fontawesome.com; form-action selfContent-Type: text/html; charsetUTF-8ETag: 1764606227Expect-CT: max-age0, report-uri/report-expect-ct-violationFeature-Policy: accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr noneFrom-Origin: sameLast-Modified: Mon, 01 Dec 2025 16:23:47 GMTReferrer-Policy: no-referrer-when-downgradeStrict-Transport-Security: max-age31536000; includeSubDomainsX-Age: 331X-Cache-Hits: 1X-Content-Type-Options: nosniffX-Drupal-Dynamic-Cache: UNCACHEABLE (poor cacheability)X-Request-ID: v-1d30c2fc-ced2-11f0-ab19-63a85c2c5775X-XSS-Protection: 1; modeblockX-EdgeConnect-MidMile-RTT: 0X-EdgeConnect-Origin-MEX-Latency: 60Cache-Control: public, max-age0, s-maxage2700Expires: Mon, 01 Dec 2025 16:29:20 GMTDate: Mon, 01 Dec 2025 16:29:20 GMTTransfer-Encoding: chunkedConnection: keep-aliveConnection: Transfer-Encoding !DOCTYPE html>html langen dirltr prefixog: https://ogp.me/ns#> head> meta charsetutf-8 />meta namedescription contentPalvella Therapeutics Investor relations (IR) website contains information about our business for stockholders, potential investors, and financial analysts. />link relcanonical hrefhttps://ir.palvellatx.com/investor-relations/ />link relshortlink hrefhttps://palvellatx.gcs-web.com/ />meta namereferrer contentno-referrer />meta propertyog:site_name contentPalvella Therapeutics />meta propertyog:type contentwebsite />meta propertyog:url contenthttps://ir.palvellatx.com/investor-relations />meta propertyog:title contentInvestor Relations - Palvella Therapeutics />meta propertyog:description contentPalvella Therapeutics Investor relations (IR) website contains information about our business for stockholders, potential investors, and financial analysts. />meta nameGenerator contentDrupal 10 (https://www.drupal.org) />meta nameMobileOptimized contentwidth />meta nameHandheldFriendly contenttrue />meta nameviewport contentwidthdevice-width, initial-scale1.0 />link relicon href/sites/g/files/knoqqb96821/files/favicon_palvella.png typeimage/png />link relalternate hreflangen hrefhttps://ir.palvellatx.com/ /> title>Investor Relations - Palvella Therapeutics/title> link relstylesheet mediaall href/sites/g/files/knoqqb96821/files/css/css_Wlq7Lt5eF5HfWyBgeg1fk_OIbFuDRtvTPvYJ3J3dAWc.css?delta0&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall href/sites/g/files/knoqqb96821/files/css/css_RcaJY1bRd5cxGENbn0Jh16ZBirLfMZ90i9bZD5quZTo.css?delta1&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall hrefhttps://use.fontawesome.com/releases/v6.4.2/css/all.css />link relstylesheet mediaall hrefhttps://fonts.googleapis.com/icon?familyMaterial+Icons />link relstylesheet mediaall hrefhttps://fonts.googleapis.com/css2?familyMaterial+Symbols+Outlined:opsz,wght,FILL,GRAD@20..48,100..700,0..1,-50..200 />link relstylesheet mediaall hrefhttps://unpkg.com/aos@2.3.1/dist/aos.css />link relstylesheet mediaall hrefhttps://unpkg.com/swiper@8/swiper-bundle.min.css />link relstylesheet mediaall href/sites/g/files/knoqqb96821/files/css/css_ILwIp_OvxM51DPzt0CPhLaROaOls5sVuoKGbkGZr8xg.css?delta7&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaprint href/sites/g/files/knoqqb96821/files/css/css_otANj3azA1FTWY-T6a4kEyDUaITewkJ7thzFPfmD8Lw.css?delta8&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall href/sites/g/files/knoqqb96821/files/css/css_hUVXwHxISoNU5CxYOm7b6WEMICvNZS03zIsCcb8WI10.css?delta9&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA />link relstylesheet mediaall hrefhttps://fonts.googleapis.com/css?familyOutfit%3A300%2C400%2C800%7CDM+Serif+Display%3A400&ver6.4.2" />link relstylesheet mediaall href/sites/g/files/knoqqb96821/files/css/css__iPOBwp369x0OMd7K38mypoi4pWeBh4pHuQL5cT_fEw.css?delta11&languageen&themeclient_site&includeeJyNj80OgzAMg18I0UeKTIhYRpuiNPvh7VfYZTtM2u2TZSc2ZxULahqS6l384Z3awNUlzX7bkEdc8fwSZkWuy2DqNKFJOkC5WjulAl8laEaAplx5TTDkvQU5Qm3pGSe-wOMve6PAlOWHtwiMXLiWItZ1rfZxe8PybnfA2BvGuXU37iXMxIfWH0lJx4wXu3lpRA /> script src/core/assets/vendor/modernizr/modernizr.min.js?v3.11.7>/script>script src/sites/g/files/knoqqb96821/files/js/js_W3W-doX3CGtV1anfNLt81iUQEVKVj4OxqiDTSWgbqqQ.js?scopeheader&delta1&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script> /head> body classnir-node nir-node--type-nir-landing-page nir-node--5806 reborn_lite material salient wpb-js-composer js-comp-ver-7.1 vc_responsive path-frontpage page-node-type-nir-landing-page data-footer-revealfalse data-footer-reveal-shadownone data-header-formatdefault data-body-borderoff data-header-breakpoint1176 data-dropdown-styleminimal data-caeeaseOutCubic data-cad750 data-megamenu-widthcontained data-aienone data-lsfancybox data-aptestandard data-hhun1 data-fancy-form-rcsdefault data-form-styleregular data-isminimal data-button-styleslightly_rounded data-user-account-buttonfalse data-flex-colstrue data-col-gap60px data-header-inherit-rcfalse data-header-searchfalse data-animated-anchorstrue data-ajax-transitionsfalse data-full-width-headerfalse data-slide-out-widget-areatrue data-slide-out-widget-area-stylefullscreen data-user-set-ocmoff data-loading-animationnone data-bg-headerfalse data-responsive1 data-ext-responsivetrue data-ext-padding60 data-header-colorcustom data-transparent-headerfalse data-cartfalse data-force-header-trans-colorlight data-permanent-transparentfalse> div idskip> a classvisually-hidden focusable skip-link href#main-menu> Skip to main navigation /a> /div> div classdialog-off-canvas-main-canvas data-off-canvas-main-canvas> div classocm-effect-wrap> div classocm-effect-wrap-inner> div idheader-space data-header-mobile-fixedfalse>/div> div idheader-outer data-has-menutrue data-has-buttonsno data-header-button_styledefault data-using-pr-menufalse data-mobile-fixedfalse data-ptnmfalse data-lheanimated_underline data-user-set-bg#1b1b32 data-formatdefault data-permanent-transparentfalse data-megamenu-rt0 data-remove-fixed1 data-header-resize0 data-cartfalse data-transparency-option0 data-box-shadowlarge data-shrink-num6 data-using-secondary0 data-using-logo1 data-logo-height45 data-m-logo-height40 data-padding20 data-full-widthfalse data-condensefalse > div idsearch-outer classnectar> div idsearch> div classcontainer> div idsearch-box> div classinner-wrap> div classcol span_12> form rolesearch actionhttps://palvellatx.com/ methodGET> input typetext names value aria-labelSearch|t placeholderSearch/> span>Hit enter to search or ESC to close/span> /form> /div> !--/span_12--> /div> !--/inner-wrap--> /div> !--/search-box--> div idclose> a href# aria-labelclose search> span classscreen-reader-text>Close Search/span> span classclose-wrap aria-hiddentrue> span classclose-line close-line1>/span> span classclose-line close-line2>/span> /span> /a> /div> /div> !--/container--> /div> !--/search--> /div> !--/search-outer--> header idtop> div classcontainer> div classrow> div classcol span_3> a idlogo classlogo-link hrefhttps://palvellatx.com data-supplied-ml-starting-darkfalse data-supplied-ml-startingfalse data-supplied-mlfalse target_blank> img classstnd skip-lazy dark-version width0 height0 altPalvella Therapeutics corporate home page src/sites/g/files/knoqqb96821/themes/site/client_site/dist/wp-content/uploads/2024/06/Logo-No-Wave.svg/> /a> /div> !--/span_3--> div classcol span_9 col_last> div classnectar-mobile-only mobile-header> div classinner>/div> /div> div classslide-out-widget-area-toggle mobile-icon fullscreen data-custom-colorfalse data-icon-animationsimple-transform> div> a href#sidewidgetarea rolebutton aria-labelNavigation Menu aria-expandedfalse classclosed> span classscreen-reader-text>Menu/span> span aria-hiddentrue> div classlines-button x2> div classlines>/div> /div> /span> /a> /div> /div> nav classmain-nav aria-labelmain navigation> ul data-block-uuid12b54afa-dddd-4aa3-aff6-8ec5fd149d83 classsf-menu> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a hrefhttps://palvellatx.com/about/ aria-labelabout>span classmenu-title-text>About/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a hrefhttps://palvellatx.com/platform/ aria-labelplatform>span classmenu-title-text>Platform/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item menu-item-has-children> a hrefhttps://palvellatx.com/programs/ aria-labelprograms--research>span classmenu-title-text>Programs & Research/span>/a> ul classsub-menu> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a hrefhttps://palvellatx.com/programs/ aria-labelpipeline--programs>span classmenu-title-text>Pipeline & Programs/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a hrefhttps://palvellatx.com/publications-and-presentations/ aria-labelpublications--presentations>span classmenu-title-text>Publications & Presentations/span>/a> /li> /ul> /li> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item menu-item-has-children menu-item--active-trail current-menu-item> a href/investor-relations aria-labelinvestors data-drupal-link-system-pathnode/5806 classis-active aria-currentpage>span classmenu-title-text>Investors/span>/a> ul classsub-menu> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a href/investor-relations aria-labeloverview data-drupal-link-system-pathnode/5806 classis-active aria-currentpage>span classmenu-title-text>Overview/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a href/news-events/press-releases aria-labelnews--events data-drupal-link-system-pathnode/5816>span classmenu-title-text>News & Events/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a href/financials-filings/sec-filings aria-labelfinancials--filings data-drupal-link-system-pathnode/6016>span classmenu-title-text>Financials & Filings/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a href/stock-information/stock-quote-chart aria-labelstock-information data-drupal-link-system-pathnode/5911>span classmenu-title-text>Stock Information/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a href/corporate-governance/documents-charters aria-labelcorporate-governance data-drupal-link-system-pathnode/5836>span classmenu-title-text>Corporate Governance/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a href/shareholder-services/investor-faqs aria-labelshareholder-services data-drupal-link-system-pathnode/5941>span classmenu-title-text>Shareholder Services/span>/a> /li> /ul> /li> li classmenu-item menu-item-type-post_type menu-item-object-page nectar-regular-menu-item> a hrefhttps://palvellatx.com/advocacy-partnerships/ aria-labeladvocacy---partnerships>span classmenu-title-text>Advocacy / Partnerships/span>/a> /li> /ul> ul classbuttons sf-menu data-user-set-ocmoff>/ul> /nav> /div> !--/span_9--> /div> !--/row--> /div> !--/container--> /header> /div> div idajax-content-wrap> div classblurred-wrap> div classcontainer-wrap> div classcontainer main-content rolemain> div classrow> div idhero-banner fws_67322f4b21ba3 data-column-margindefault data-midnightdark data-top-percent6% data-bottom-percent6% classwpb_row vc_row-fluid vc_row top-level full-width-section parallax_section tt-banner tt-bg--contain top_padding_tablet_200px top_padding_phone_200px bottom_padding_tablet_10pct bottom_padding_phone_10pct> div classrow-bg-wrap data-bg-animationnone data-bg-animation-delay data-bg-overlayfalse> div classinner-wrap row-bg-layer using-image> div classrow-bg viewport-desktop using-image using-bg-color data-parallax-speedmedium>/div> /div> div classrow-bg-overlay row-bg-layer>/div> /div> div classnectar-shape-divider-wrap data-height100 data-fronttrue data-stylewaves data-positionbottom aria-hiddentrue> svg classnectar-shape-divider aria-hiddentrue fill#ffffff xmlnshttp://www.w3.org/2000/svg viewbox0 0 1000 300 preserveaspectrationone> path dM 1000 300 l 1 -230.29 c -217 -12.71 -300.47 129.15 -404 156.29 c -103 27 -174 -30 -257 -29 c -80 1 -130.09 37.07 -214 70 c -61.23 24 -108 15.61 -126 10.61 v 22.39 z>/path> /svg> /div> div classrow_col_wrap_12 col span_12 dark left> div classvc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone data-padding-posall data-has-bg-colorfalse data-bg-color data-bg-opacity1 data-animation data-delay0> div classvc_column-inner> div classwpb_wrapper> div classnectar-responsive-text tt-hero__title font_size_desktop_72px font_size_tablet_48px font_size_phone_42px font_line_height_1-2 nectar-link-underline-effect> h1>Investor Relations/h1> /div> div classnectar-responsive-text tt-hero__subtitle font_size_desktop_30px font_size_tablet_24px font_line_height_1-4 nectar-link-underline-effect> div classregion region-hero-content> div idblock-client-site-gbherocontentinvestor classblock-content--nir-global-block block-content--nir-global-block--9256 block--block-contenteeeb2224-1da4-4f71-9d6d-f1452174b390 block--block-contenteeeb2224-1da4-4f71-9d6d-f1452174b390--5806 block--hero-content--block-content--eeeb2224-1da4-4f71-9d6d-f1452174b390 block--hero-content--block-content--eeeb2224-1da4-4f71-9d6d-f1452174b390--5806 block--122c97e3-e123-4a9a-a729-11ba3a2d7261 block--122c97e3-e123-4a9a-a729-11ba3a2d7261--5806 block block-block-content block-block-contenteeeb2224-1da4-4f71-9d6d-f1452174b390> div classfield field--name-field-nir-global-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>h2>Maximizing opportunities to serve./h2>/div> /div> /div> /div> /div> /div> /div> /div> /div> /div> div classlf-5806 idlfg-content> div classregion region-content> div data-drupal-messages-fallback classhidden>/div>div idblock-client-site-content classblock--system-main-block block--system-main-block--5806 block--content--system-main-block block--content--system-main-block--5806 block--b70e217a-03d2-4ac8-a1d3-d69fc865fd27 block--b70e217a-03d2-4ac8-a1d3-d69fc865fd27--5806 block block-system block-system-main-block> article classnode node--type-nir_landing_page node--view-mode-full clearfix> div> div classpanel-display pond clearfix > section classpy-5> div classrow gx-5 gy-4 gy-md-0 justify-content-between> div classcol-md-6 col-xl-5> div classradix-layouts-header panel-panel> div classpanel-panel-inner> div classblock-region-header>div classblock-content--nir-lp-block block-content--nir-lp-block--6351 block--block-content072f05c0-2882-4425-800b-8d9c32b5a1ed block--block-content072f05c0-2882-4425-800b-8d9c32b5a1ed--5806 block--header--block-content--072f05c0-2882-4425-800b-8d9c32b5a1ed block--header--block-content--072f05c0-2882-4425-800b-8d9c32b5a1ed--5806 block--3967ef8d-42fa-427a-af31-0ed269ec581e block--3967ef8d-42fa-427a-af31-0ed269ec581e--5806 block block-block-content block-block-content072f05c0-2882-4425-800b-8d9c32b5a1ed> div classfield field--name-field-nir-lp-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-lp-block-body field--type-text-long field--label-hidden field__item>h2 classh6 mb-0>span classfont-14 ndm-eyebrow>Corporate Profile/span>/h2>!--h3 classnectar-responsive-text tt-section-title font_size_desktop_36px font_size_tablet_30px font_size_phone_24px font_line_height_1-2 nectar-link-underline-effect> Rare Is Everywhere.br> Let’s Treat It./h3-->p>Palvella Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. Palvella is developing a broad pipeline of product candidates based on its patented QTORIN™ platform. Palvella’s lead product candidate, QTORIN 3.9% rapamycin anhydrous gel (QTORIN™ rapamycin), is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations./p>/div> /div> /div>/div> /div> /div> /div> div classcol-md-6> div classbg-l-gray p-5 radix-layouts-column1 panel-panel> div classpanel-panel-inner> div classblock-region-column1>div classblock--nir-assets__widget block--nir-assets__widget--5806 block--column1--nir-assets__widget block--column1--nir-assets__widget--5806 block--71ea5cd7-d048-4d7f-9bc8-23c4b85364f7 block--71ea5cd7-d048-4d7f-9bc8-23c4b85364f7--5806 block block-nir-assets block-nir-assets__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> h2 classnectar-responsive-text tt-section-title font_size_desktop_36px font_size_tablet_30px font_size_phone_24px font_line_height_1-2 nectar-link-underline-effect>Corporate Presentation/h2> div classnir-widget--content> div classnir-widget--list > article classclearfix node node--nir-asset--nir-widget-list node--type-nir-asset node--view-mode-nir-widget-list nir-widget-article llf-border data-titleCorporate Presentation> div classllf-container-fluid-full> div classllf-row llf-no-gutters llf-flex-sm-nowrap> div classllf-col llf-pr-sm-2 llf-mb-2 llf-mb-sm-0 llf-text-center llf-text-center nir-widget--field nir-widget--asset--thumbnail float-left> div classfield-nir-thumbnail> div classfield__item>img src/system/files-encrypted/styles/nir_asset_small/encrypt/nasdaq_kms/assets/2025/11/06/10-05-44/November%202025%20Presentation%20Image.png?itoktX3rip6z altCorporate Presentation classimage-style-nir-asset-small />/div> /div> /div> div classllf-col llf-px-0 lfg-details> div classnir-widget--field nir-widget--asset--list-of-files> div classfield-nir-document> div classnir-widgets--file-list--hide-filesize field__item>article classnode node--nir-asset--asset-link node--type-nir-asset node--view-mode-asset-link> div classnode__content> div classfield field--name-field-nir-document field--type-file field--label-hidden field__items> div classfield__item> div classfile-link data-typeapplication/pdf> span classfile file--mime-application-pdf file--application-pdf> a href/static-files/250b133c-b50c-4c99-8f02-529d77ccc92e typeapplication/pdf titlePalvella Therapeutics Corporate Presentation - November 2025 For Website.pdf>Corporate Presentation/a>/span> /div> /div> /div> /div>/article>/div> /div> /div> /div> /div> /div>/article> /div> /div> /div> /div> /div> /div>/div> /div> /div> /div> /div> /section> section classpy-5 home-news> div classradix-layouts-column2 panel-panel> div classpanel-panel-inner> div classblock-region-column2>div classblock--tw-news-millennium block--nir-news__widget block--nir-news__widget--5806 block--column2--nir-news__widget block--column2--nir-news__widget--5806 block--e098c76b-2921-4a45-9a4c-54d28d0ec8b5 block--e098c76b-2921-4a45-9a4c-54d28d0ec8b5--5806 block block-nir-news block-nir-news__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> div classd-flex flex-row justify-content-between align-items-end home-bund> h2 classnectar-responsive-text tt-section-title font_size_desktop_36px font_size_tablet_30px font_size_phone_24px font_line_height_1-2 nectar-link-underline-effect>News Releases/h2> div classtext-md-end weight-bold lh-1 ps-3> a hrefhttps://ir.palvellatx.com/news-events/press-releases classndm-learn-more ndm-hover-fill color-body lh-1>span>All News Releases/span>/a> /div> /div> div classnir-widget--content> div classnir-widget--list > div classrow row-cols-1 row-cols-sm-2 row-cols-xl-3 gx-5 gy-5 pt-4> article classclearfix node node--nir-news--nir-widget-list node--type-nir-news node--view-mode-nir-widget-list node--promoted data-titlePalvella Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update> div classllf-col-md-12 llf-px-0 lfg-details > div classnir-widget--field nir-widget--news--date-time data-labelDate> November 11, 2025 /div> div classnir-widget--field data-labelTitle> a classnir-widget--field nir-widget--news--headline href/news-releases/news-release-details/palvella-therapeutics-reports-third-quarter-2025-financial>Palvella Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update/a> /div> /div> /article> article classclearfix node node--nir-news--nir-widget-list node--type-nir-news node--view-mode-nir-widget-list node--promoted data-titlePalvella Therapeutics to Present at the Stifel 2025 Healthcare Conference> div classllf-col-md-12 llf-px-0 lfg-details > div classnir-widget--field nir-widget--news--date-time data-labelDate> November 6, 2025 /div> div classnir-widget--field data-labelTitle> a classnir-widget--field nir-widget--news--headline href/news-releases/news-release-details/palvella-therapeutics-present-stifel-2025-healthcare-conference>Palvella Therapeutics to Present at the Stifel 2025 Healthcare Conference/a> /div> /div> /article> article classclearfix node node--nir-news--nir-widget-list node--type-nir-news node--view-mode-nir-widget-list node--promoted data-titlePalvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare, Chronic, and Pre-Cancerous Genetic Skin Disease with No FDA-Approved Therapies> div classllf-col-md-12 llf-px-0 lfg-details > div classnir-widget--field nir-widget--news--date-time data-labelDate> November 5, 2025 /div> div classnir-widget--field data-labelTitle> a classnir-widget--field nir-widget--news--headline href/news-releases/news-release-details/palvella-therapeutics-announces-new-qtorintm-product-candidate>Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare, Chronic, and Pre-Cancerous Genetic Skin Disease with No FDA-Approved Therapies/a> /div> /div> /article> /div> /div> /div> /div> /div> /div> /div>/div> /div> /div> /section> section classpy-5 home-alerts-section d-print-none> div classradix-layouts-secondarycolumn1 panel-panel h-100> div classpanel-panel-inner h-100> div classblock-region-secondarycolumn1>div classblock-content--nir-global-block block-content--nir-global-block--6486 block--block-contentf44f1cb9-7a9e-494b-8fe1-5200540d3ce8 block--block-contentf44f1cb9-7a9e-494b-8fe1-5200540d3ce8--5806 block--secondarycolumn1--block-content--f44f1cb9-7a9e-494b-8fe1-5200540d3ce8 block--secondarycolumn1--block-content--f44f1cb9-7a9e-494b-8fe1-5200540d3ce8--5806 block--dc17461f-fc42-4a4e-a5a1-8c5f6d4d7a7d block--dc17461f-fc42-4a4e-a5a1-8c5f6d4d7a7d--5806 block block-block-content block-block-contentf44f1cb9-7a9e-494b-8fe1-5200540d3ce8> div classfield field--name-field-nir-global-block-node field--type-entity-reference field--label-hidden field__item> div classfield field--name-field-nir-global-block-body field--type-text-long field--label-hidden field__item>div classp-5 bg-gradient bg-dark rounded-3>form classfooter-alerts-form action/shareholder-services/email-alerts>div classrow row-cols-1 row-cols-sm-2 gy-4 justify-content-between align-items-center>div classcol col-xl-5 col-xxl-4>h2 classh6 mb-0>span classndm-eyebrow bg-transparent font-14 text-white p-0>Email Alerts/span>/h2>p classh4 d-block mb-0>Subscribe to Investor Email Alerts/p>/div>div classcol col-xl-5>p>!-- p> Get new updates directly to your inbox /p> -->Email Addressspan classreq-symbol aria-hiddentrue>*/span>span classvisually-hidden> Required/span>/p>div classrow g-3>div classcol>input classform-control h-100 idhome_email typeemail aria-labelEnter Email Address>/div>div classcol-auto>button classbtn btn-outline-light mb-0 typesubmit>Submit/button>/div>/div>/div>/div>/form>/div>/div> /div> /div>/div> /div> /div> /section> section classpy-5 home-events> div classradix-layouts-secondarycolumn2 panel-panel> div classpanel-panel-inner> div classblock-region-secondarycolumn2>div classblock--tw-events-millennium block--nir-events__widget block--nir-events__widget--5806 block--secondarycolumn2--nir-events__widget block--secondarycolumn2--nir-events__widget--5806 block--1257d3f5-171e-4d92-8ae6-600946239290 block--1257d3f5-171e-4d92-8ae6-600946239290--5806 block block-nir-events block-nir-events__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> div classd-flex flex-row justify-content-between align-items-end mb-4> div> h2 classnectar-responsive-text tt-section-title font_size_desktop_36px font_size_tablet_30px font_size_phone_24px font_line_height_1-2 nectar-link-underline-effect>Events/h2> /div> div classtext-md-end weight-bold lh-1 ps-3> a hrefhttps://ir.palvellatx.com/news-events/events classndm-learn-more ndm-hover-fill color-body lh-1>span>All Events/span>/a> /div> /div> div classnir-widget--content> div classnir-widget--list > article classlfg-no-content nir-widget-article>Investor events will be posted soon./article> /div> /div> /div> /div> /div> /div>div classblock--tw-events-millennium block--nir-events__widget block--nir-events__widget--5806 block--secondarycolumn2--nir-events__widget block--secondarycolumn2--nir-events__widget--5806 block--2d99b7aa-806a-4254-af75-21f093b60c68 block--2d99b7aa-806a-4254-af75-21f093b60c68--5806 block block-nir-events block-nir-events__widget> div classnir-widget llf-container-fluid-full> div classllf-row llf-no-gutters> div classllf-col-12> div classnir-widget--content> div classnir-widget--list > article classclearfix node node--nir-event--nir-widget-list node--type-nir-event node--view-mode-nir-widget-list d-flex align-items-center border-bottom py-4 row gx-0 home-event-item data-titleStifel 2025 Healthcare Conference> h3 classh6 mb-0>span classndm-eyebrow font-14>Past Event/span>/h3> div classcol-12 home-event-item-details> div classd-flex justify-content-between w-100> div classflex-grow-1 pe-4> div classnir-widget--field nir-widget--event--title> a href/events/event-details/stifel-2025-healthcare-conference classcolor-body>Stifel 2025 Healthcare Conference/a> /div> div classnir-widget--field nir-widget--event--date> November 12, 2025 span classlfg_time>4:00 PM EST/span> /div> /div> div classd-print-none> span classbtn-galaxy-black-arrow-right justify-content-between no-border aria-hiddentrue> span>/span> /span> /div> /div> /div>/article> /div> /div> /div> /div> /div> /div>/div> /div> /div> /section> section classpy-5 home-esg-section> div classradix-layouts-footer panel-panel> div classpanel-panel-inner> div classblock-region-footer>div classblock--market-data-block__stock-quote block--market-data-block__stock-quote--5806 block--footer--market-data-block__stock-quote block--footer--market-data-block__stock-quote--5806 block--d39ef897-e008-4012-ae17-3066e2ceb8e7 block--d39ef897-e008-4012-ae17-3066e2ceb8e7--5806 block block-nir-market-data-block block-market-data-block__stock-quote data-storage-idnode:5806:full:20686 data-uuidd39ef897-e008-4012-ae17-3066e2ceb8e7> h2 classnectar-responsive-text tt-section-title font_size_desktop_36px font_size_tablet_30px font_size_phone_24px font_line_height_1-2 nectar-link-underline-effect>Stock Quote/h2> div classquote-wrap user-toggle-off long-quote > div classquote-wrapper> div classstock-quote lfg-stock-quote llf-container-fluid data-exchange> div classllf-row llf-align-items-center llf-align-items-stretch> div classllf-col-lg-3 llf-col-12 lfg-price-container> div classexchange>/div> div classquote-price >/div> time>/time> /div> div classllf-col-lg-9 llf-col-md-12 llf-col-sm-12 llf-d-flex> div classllf-row llf-flex-grow-1> div classlfg-stock-data-column llf-col-md-6 llf-d-flex llf-flex-column llf-justify-content-between> div classllf-row stock-price-change> div classllf-col-6 lfg-stock-label>Change/div> div classllf-col-6 lfg-stock-data >/div> /div> div classllf-row stock-volume> div classllf-col-6 lfg-stock-label>Volume/div> div classllf-col-6 lfg-stock-data>/div> /div> div classllf-row stock-day-open> div classllf-col-6 lfg-stock-label>Todays Open/div> div classllf-col-6 lfg-stock-data>/div> /div> div classllf-row stock-prev-close> div classllf-col-6 lfg-stock-label>Previous Close/div> div classllf-col-6 lfg-stock-data>/div> /div> /div> div classlfg-stock-data-column llf-col-md-6 llf-d-flex llf-flex-column llf-justify-content-between> div classllf-row stock-day-high> div classllf-col-6 lfg-stock-label>Todays High/div> div classllf-col-6 lfg-stock-data>/div> /div> div classllf-row stock-day-low> div classllf-col-6 lfg-stock-label>Todays Low/div> div classllf-col-6 lfg-stock-data>/div> /div> div classllf-row stock-year-high> div classllf-col-6 lfg-stock-label>52 Week High/div> div classllf-col-6 lfg-stock-data>/div> /div> div classllf-row stock-year-low> div classllf-col-6 lfg-stock-label>52 Week Low/div> div classllf-col-6 lfg-stock-data>/div> /div> /div> /div> /div> /div> /div> /div>/div> /div>div classblock--attribution-block__stock-info-attribution__thomson-reuters block--attribution-block__stock-info-attribution__thomson-reuters--5806 block--footer--attribution-block__stock-info-attribution__thomson-reuters block--footer--attribution-block__stock-info-attribution__thomson-reuters--5806 block--2b0b8575-87be-4a73-907b-e650b4cf5185 block--2b0b8575-87be-4a73-907b-e650b4cf5185--5806 block block-nir-attribution-block block-attribution-block__stock-info-attribution__thomson-reuters> p classattribution-legend> Minimum 15 minutes delayed. Source: LSEG/p> /div>/div> /div> /div> /section> /div>!-- /.radix-pond --> /div>/article> /div>div idblock-client-site-websitenoticeblock classblock--website-notice-block block--website-notice-block--5806 block--content--website-notice-block block--content--website-notice-block--5806 block--d1abe548-2dfc-4d2a-9505-52de06454d52 block--d1abe548-2dfc-4d2a-9505-52de06454d52--5806 block block-nir-website-notices block-website-notice-block> /div> /div> /div> section classpy-5> div classregion region-quick-links> nav aria-labelQuick Links idblock-quicklinks classblock--system-menu-blockquicklinks block--system-menu-blockquicklinks--5806 block--quick-links--system-menu-block--quicklinks block--quick-links--system-menu-block--quicklinks--5806 block--45025d93-1ff0-4681-bb11-b18fa6bf200a block--45025d93-1ff0-4681-bb11-b18fa6bf200a--5806 block block-menu navigation block-system-menublock menu--quicklinks> h2 classnectar-responsive-text tt-section-title font_size_desktop_36px font_size_tablet_30px font_size_phone_24px font_line_height_1-2 nectar-link-underline-effect>Quicklinks/h2> div classrow row-cols-1 row-cols-md-2 row-cols-xl-3 gx-2 gy-2 rolelist> div class rolelistitem> a href/financials-filings/sec-filings classh-100 d-flex flex-column justify-content-center align-items-center px-4 ndm-pt-7 ndm-pb-7 bg-dark text-center rounded-3 text-white hover-scale-1> div classh3>SEC Filings/div> /a> /div> div class rolelistitem> a href/news-events/events-presentations classh-100 d-flex flex-column justify-content-center align-items-center px-4 ndm-pt-7 ndm-pb-7 bg-dark text-center rounded-3 text-white hover-scale-1> div classh3>Investor Presentations/div> /a> /div> div class rolelistitem> a href/shareholder-services/contact-ir classh-100 d-flex flex-column justify-content-center align-items-center px-4 ndm-pt-7 ndm-pb-7 bg-dark text-center rounded-3 text-white hover-scale-1> div classh3>Investor Inquiries/div> /a> /div> /div> /nav> /div> /section> /div> /div> /div> div idfooter-outer data-midnightlight data-cols4 data-custom-colortrue data-disable-copyrightfalse data-matching-section-colortrue data-copyright-linefalse data-using-bg-imgfalse data-bg-img-overlay0.8 data-full-widthfalse data-using-widget-areatrue data-link-hoverdefault > div idfooter-widgets data-has-widgetsfalse data-cols4> div classcontainer> div classrow> div classcol span_3> div classwidget>/div> /div> div classcol span_3> div classwidget>/div> /div> div classcol span_3> div classwidget>/div> /div> div classcol span_3> div classwidget>/div> /div> /div> /div> !--/container--> /div> !--/footer-widgets--> div classrow idcopyright data-layoutcentered> div classcontainer> div classcol span_5> div classwidget>/div> p> © 2025 Palvella Therapeutics. /p> /div> !--/span_5--> div classcol span_7 col_last> ul classsocial>/ul> /div> !--/span_7--> /div> !--/container--> /div> !--/row--> /div> !--/footer-outer--> /div> !--blurred-wrap--> div idslide-out-widget-area-bg classfullscreen dark>/div> div idslide-out-widget-area classfullscreen data-dropdown-funcdefault data-back-txtBack> div classinner-wrap> div classinner data-prepend-menu-mobilefalse> a classslide_out_area_close href# aria-labelclose menu button> span classscreen-reader-text>Close Menu/span> span classclose-wrap> span classclose-line close-line1>/span> span classclose-line close-line2>/span> /span> /a> div classoff-canvas-menu-container mobile-only rolenavigation aria-labelmobile navigation> ul data-block-uuid92d654da-24fe-4b4a-8cd1-0634c35a8180 classmenu> li classmenu-item menu-item-type-post_type menu-item-object-page> a hrefhttps://palvellatx.com/about/ target_blank aria-labelabout>span classmenu-title-text>About/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page> a hrefhttps://palvellatx.com/platform/ target_blank aria-labelplatform>span classmenu-title-text>Platform/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page menu-item-has-children> a hrefhttps://palvellatx.com/programs/ target_blank aria-labelprograms--research>span classmenu-title-text>Programs & Research/span>/a> ul classsub-menu> li classmenu-item menu-item-type-post_type menu-item-object-page> a hrefhttps://palvellatx.com/programs/ target_blank aria-labelpipeline--programs>span classmenu-title-text>Pipeline & Programs/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page> a hrefhttps://palvellatx.com/publications-and-presentations/ target_blank aria-labelpublications--presentations>span classmenu-title-text>Publications & Presentations/span>/a> /li> /ul> /li> li classmenu-item menu-item-type-post_type menu-item-object-page menu-item-has-children menu-item--active-trail current-menu-item current_page_item> a href/investor-relations aria-labelinvestors data-drupal-link-system-pathnode/5806 classis-active aria-currentpage>span classmenu-title-text>Investors/span>/a> ul classsub-menu> li classmenu-item menu-item-type-post_type menu-item-object-page> a href/investor-relations aria-labeloverview data-drupal-link-system-pathnode/5806 classis-active aria-currentpage>span classmenu-title-text>Overview/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page> a href/news-events/press-releases aria-labelnews--events data-drupal-link-system-pathnode/5816>span classmenu-title-text>News & Events/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page> a href/financials-filings/sec-filings aria-labelfinancials--filings data-drupal-link-system-pathnode/6016>span classmenu-title-text>Financials & Filings/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page> a href/stock-information/stock-quote-chart aria-labelstock-information data-drupal-link-system-pathnode/5911>span classmenu-title-text>Stock Information/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page> a href/corporate-governance/documents-charters aria-labelcorporate-governance data-drupal-link-system-pathnode/5836>span classmenu-title-text>Corporate Governance/span>/a> /li> li classmenu-item menu-item-type-post_type menu-item-object-page> a href/shareholder-services/investor-faqs aria-labelshareholder-services data-drupal-link-system-pathnode/5941>span classmenu-title-text>Shareholder Services/span>/a> /li> /ul> /li> li classmenu-item menu-item-type-post_type menu-item-object-page> a hrefhttps://palvellatx.com/advocacy-partnerships/ target_blank aria-labeladvocacy---partnerships>span classmenu-title-text>Advocacy / Partnerships/span>/a> /li> /ul> ul classmenu secondary-header-items>/ul> /div> /div> div classbottom-meta-wrap>/div> !--/bottom-meta-wrap--> /div> !--/inner-wrap--> /div> /div> !--/ajax-content-wrap--> /div>/div>!-- Video Modal -->div classndm-modal fade idvideoModal tabindex-1 roledialog aria-labelVideo Modal aria-hiddentrue> div classndm-modal-dialog ndm-modal-dialog-centered ndm-modal-xl> div classndm-modal-content> div classndm-modal-header> button typebutton classbtn-close data-bs-dismissndm-modal aria-labelClose>/button> /div> div classndm-modal-body> div classvideoWrapper>iframe titlevideo-player src>/iframe>/div> /div> /div> /div>/div>!-- Bio Modal -->div classndm-modal bios-modal fade idmodalBio tabindex-1 roledialog aria-labelledbymodalBioTitle aria-hiddentrue> div classndm-modal-dialog ndm-modal-dialog-centered ndm-modal-lg roledocument> div classndm-modal-content border-0 p-4 idm-rounded> div classndm-modal-header> div classrow w-100 d-flex flex-row-reverse> div classcol text-end> button typebutton classbtn-close data-bs-dismissndm-modal aria-labelClose>/button> /div> div classcol-sm-12 col-md-6 col-lg-5 align-self-end> div classh4 mb-0 modal-bio-name text-primary idmodalBioTitle>!-- dynamic from JS -->/div> div classh5 body-font mb-0 modal-bio-title>!-- dynamic from JS -->/div> /div> div classcol-sm-12 col-md-4 col-lg-3 > div classportrait modal-bio-pic> !-- dynamic from JS --> /div> /div> /div> /div> div classndm-modal-body modal-bio-body>!-- dynamic from JS -->/div> /div> /div>/div>!-- Bio Offcanvas -->div classoffcanvas offcanvas-end bios-offcanvas tabindex-1 idbioCanvas aria-labelledbybiosOffcanvasLabel> div classoffcanvas-header flex-column-reverse> div classalign-self-start w-100> div classrow w-100> div classcol-md-3> div classportrait mt-5 offcanvas-bio-pic> !-- dynamic from JS --> /div> /div> div classcol-md-9> div classh4 offcanvas-title mt-5 offcanvas-bio-name idbiosOffcanvasLabel>!-- dynamic from JS -->/div> div class offcanvas-bio-title h6 body-font>!-- dynamic from JS -->/div> /div> /div> /div> button typebutton classbtn-close text-reset align-self-end data-bs-dismissoffcanvas aria-labelClose>/button> /div> div classoffcanvas-body> div classoffcanvas-bio-body>!-- dynamic from JS -->/div> /div>/div>!-- Search Modal -->div classndm-modal fade idsearchModal tabindex-1 aria-labelledbysearchModalLabel aria-hiddentrue> div classndm-modal-dialog ndm-modal-dialog-centered ndm-modal-lg> div classndm-modal-content> div classndm-modal-header> div classh5 modal-title idsearchModalLabel>Search Investors/div> button typebutton classbtn-close data-bs-dismissndm-modal aria-labelClose>/button> /div> div classndm-modal-body> form action/search classrow g-3> div classcol-auto flex-grow-1> label forsiteSearch classvisually-hidden>Search this site/label> input typesearch classform-control idsiteSearch placeholderSearch> /div> div classcol-auto> button typesubmit classbtn btn-primary mb-3>Submit/button> /div> /form> /div> /div> /div>/div> /div> script typetext/javascript>var s_CCSWebHostingAccount trcgpalvellatherapeutics;/script> script typeapplication/json data-drupal-selectordrupal-settings-json>{path:{baseUrl:\/,pathPrefix:,currentPath:node\/5806,currentPathIsAdmin:false,isFront:true,currentLanguage:en,themeUrl:sites\/g\/files\/knoqqb96821\/themes\/site\/client_site},pluralDelimiter:\u0003,suppressDeprecationErrors:true,ajaxPageState:{libraries:eJyVUgFuwyAM_FAV3rIXWAaslgXsynbW5vcjpFKVqZs6IYF9nA_kc6qF2MGKU5Av0pv2yE5cFJCxrl6ShUM2YZZIUHHhdHmDeFXJgxbRaDBKErYj5CI1og4wzZSLi0JG7ytWsvAMB6WhzuSDALFKmsN41RwUvfC5C3edC6q_RTcY2r9wGyGDUpLWiDtehP_UfolOWzly_leNed8_FvHH15bqpfXmYDim4_aK572XWzDhJ94Bc4ZU0Qywkrq94HUrfAzAyql3jZl2E24Ut5kAlm4l7c7-wKbHeVLM5d4HYpXFLRyyk_UuUwub0d8l-PZR,theme:client_site,theme_token:null},ajaxTrustedUrl:,nir_admin_use_chosen:false,nir_admin_use_select2:false,accessible_accordions:true,chairtextvars:{chairpersontext:Chair,chairtext:Chair},lfg_accordions:{no_functionality:1,speed:fast,show_text:Show All,hide_text:Hide All,show_all:0},lfg_chosen:{enabled:1,blank_text:Choose from list,disable_search:1,disable_search_threshold:10},membertextvars:{memberpersontext:Member},user:{uid:0,permissionsHash:05b4ef1c683a73ffe8f294012b8d065e5393ee8c7f5972641d379d93fb1590b9}}/script>script srchttps://code.jquery.com/jquery-3.7.0.min.js>/script>script src/sites/g/files/knoqqb96821/files/js/js_RQnMrHG8qM6UsPowNbhznIhXI3EFYehwCns849aBens.js?scopefooter&delta1&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://cdnjs.cloudflare.com/ajax/libs/waypoints/4.0.1/jquery.waypoints.min.js>/script>script src/sites/g/files/knoqqb96821/files/js/js_AMKKWzZcgTFRIvon8kCUC1KvEW_xt47NSDvAV5ytgHo.js?scopefooter&delta3&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://cdn.jsdelivr.net/npm/@popperjs/core@2.11.6/dist/umd/popper.min.js>/script>script src/sites/g/files/knoqqb96821/files/js/js_P5yvET3fDs2XnSuCXJG63c5akUKWgnCcMyHLe_jknq8.js?scopefooter&delta5&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://unpkg.com/aos@2.3.1/dist/aos.js>/script>script srchttps://unpkg.com/swiper@8/swiper-bundle.min.js>/script>script src/sites/g/files/knoqqb96821/files/js/js_oZkvoTIF3PQ-ckH0ZI06B13vemA8O-HXgXFzz536UEM.js?scopefooter&delta8&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script>script srchttps://assets.adobedtm.com/898335afd880/c52ee8aa1e90/launch-5ef258dce664.min.js crossoriginanonymous async integritysha384-9QSqHMB+yiy/V4i+d2Au+ydEWbBz4E9DqsE+oYKOnL+kj4XAZGYZxabd0P3OGHkf>/script>script src/core/assets/vendor/ckeditor5/ckeditor5-dll/ckeditor5-dll.js?v44.0.0>/script>script src/profiles/nasdaqir/modules/custom/nir_ckeditor_datatables/js/build/datatables.js?v1.10.9>/script>script src/sites/g/files/knoqqb96821/files/js/js_AVJ2oBeu1YPePipi5EwYXmgzim1cnRItN_IDIEfL8sU.js?scopefooter&delta12&languageen&themeclient_site&includeeJyVUFsOAjEIvJBpz-IJCKVE69KyaVkft7d2NWaNHxoSmBmGBCBJXAxaMvZ65nqpHbVdSRWwoNwsUfMb5jBqYBBcCh1_MM5V47DRxDGZVohoPYJw8284LBnrxDYMEERp8l9VR5ozlvjXTLOe94sar2OLWMp9I_RbOrozHti_gMMTXgFjBBJsDVC42rrwhcPjdVC0X8zrAz4096x3KCyQDg>/script> /body>/html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]